Clinical trial
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria…
NCT00171119 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00171119 |
|---|---|
| Title | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril |
| Official title | A 24-Week Study to Assess Blood Pressure Independent Effects of Valsartan Treatment, Benazepril Treatment and Combination of Both Valsartan and Benazepril Treatment on Urinary Albumin Excretion Rate With Type II Diabetes Mellitus and Microalbuminuria |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 81 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: